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journal home page: www.elsevier .com/ locat e/ i j idSoon after the novel coronavirus, SARS-CoV-2 (2019-nCoV),
was first identified in a cluster of patients with pneumonia
(Li et al., 2020), in the Chinese city of Wuhan on 31 December
2019, rapid human to human transmission was anticipated (Hui
et al., 2020). The fast pace of transmission is wreaking havoc and
stirring media hype and public health concern (Ippolito et al.,
2020) globally. When the World Health Organization (WHO)
declared the disease, (now officially named COVID-19) a Public
Health Emergency of International Concern (PHEIC) on 31st
January 2020 (WHO, 2020a), the Director General Dr Tedros
Ghebreyesus justified the decision by stating that WHOs greatest
concern was the potential for the virus to spread to countries with
weaker health systems. Repeated outbreaks of other preventable
emerging and re-emerging infectious diseases with epidemic
potential have taken their toll on the health systems of many
African countries. The devastating 2014–2016 Ebola Virus
Epidemic (WHO, 2020b) in West Africa, demonstrated how ill-
prepared the affected countries were to rapidly identify the
infection and halt transmission (WHO, 2020d; Largent, 2016;
Hoffman and Silverberg, 2018; Omoleke et al., 2016). Similarly,
the smoldering remnants of the 2018–19 Ebola Virus outbreak in
the Democratic Republic of Congo, have demonstrated even for
health services with considerable experience of dealing with a
certain emerging pathogen, geography and sociopolitical insta-
bility, can hamper the response (Aruna et al., 2019).
A recent analysis of the spatial and temporal distribution of
infectious disease epidemics, disasters and other potential public
health emergencies in the WHO Africa Region highlighted that 41
African countries (87% of the continent) had at least one epidemic,
and 21 countries (45%) had at least one epidemic annually
(Talisuna et al., 2020). The top five causes of epidemics were
Cholera, Measles, Viral haemorrhagic diseases, malaria and
meningitis. Seven countries which experienced over 10 events,
all had limited International Health Regulations (IHR) capacities
which are now being developed. Most sub-Saharan African
countries are operating at maximum capacity with the huge
existing workload in hospitals and clinics. The WHO’s Joint
External Evaluation reports, conducted since 2016, suggest that
the ability to respond to an International Health Regulation hazard,
such as the importation of an infectious disease like COVID-19,
requires almost universal improvement across sub-Saharan Africahttps://doi.org/10.1016/j.ijid.2020.02.049
1201-9712/© 2020 The Author(s). Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).(WHO, 2020c).Thus, it is essential for African countries to take the
lead, become proactive and prepare surveillance systems for the
rapid detection of any imported cases of COVID-19, to prevent
rapid spread as seen in China. The question arises, ‘Is Africa
prepared and equipped to deal with yet another outbreak of a
highly infectious disease – COVID-19?
The answer to the question is, it is better prepared than ever
before. Substantial progress has been made since the 2014–16
Ebola outbreak (WHO, 2020d), with lessons learned from previous
and ongoing outbreaks, followed by significant investments into
surveillance and preparedness (WHO, 2020d; Largent, 2016;
Hoffman and Silverberg, 2018; Omoleke et al., 2016). Africa is
now better prepared than ever before. Thus, African countries have
been on heightened alert to detect and isolated any imported cases
of COVID-19. There has been rapid response to the COVID-19
epidemic from Africa’s public health systems, well before any cases
of COVID-19 had been reported from Africa. This response has been
made possible with the re-organization of the WHO including the
creation of the World Health Emergencies Programme; the
establishment of the Africa Centers for Disease Control and
Prevention (Africa CDC, 2020) and creation and funding of
consortia such as the ONE-HUMAN-ANIMAL-HEALTH Africa-
Europe research, training and capacity development network
(PANDORA-ID-NET)(Pandora-ID-NET, 2020) for tackling emerging
and re-emerging infections with epidemic potential. This ONE-
HEALTH network works effectively and equitably together across
all Africa regions, fully engaging with national disease control
authorities and public health institutes, in close liaison with the
Nigeria CDC, Africa CDC and other African and global public health
agencies. Importantly, this consortium has allowed strengthening
of communication and establishment of trust and ‘unity of
purpose’ between African governments, Africa CDC, Nigeria CDC
(Nigeria CDC, 2020), local communities and the PANDORA-ID-NET
consortium local African and European public health workers and
scientists.
An estimated 2 million Chinese nationals live and work in
Africa, and there is increasing travel in the opposite direction, with
people going to China for education, business and leisure. Prior to
the travel restrictions imposed after the COVID-19 outbreak, there
were an average of eight flights a day operated between China and
African cities (Haider et al., 2020a,b). There are ongoing efforts inciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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outbreaks of COVID-19, led by the Africa CDC, Nigeria CDC, African
Union, PANDORA-ID-NET and other research and capacity devel-
opment and training consortia. Many African countries have
already introduced screening of arrivals for COVID-19 at airports,
and at some seaports. ‘First public health emergency responders’
from African countries met in Senegal in early February 2020 to
equip themselves with the latest advances on COVID-19 diag-
nostics (Corman et al., 2020), prevention and healthcare knowl-
edge. Over 20 African nations are now able to test for COVID-19.
Several African countries have identified isolation and quarantine
centers and Nigeria, Kenya, Ethiopia, Ivory Coast, Ghana, Uganda
and Botswana have rapidly dealt with suspected cases carrying out
laboratory tests, and in some cases, placing them in quarantine
while laboratory tests were performed.
Nigeria was one of the first countries to recognize the risk and
start planning the response for COVID-19. In a massive effort of
national coordination, a multi-sectoral National Coronavirus
Preparedness Group was established by Nigeria CDC on January
7, 2020, one week after China first reported the cases and three
weeks before WHO declared the disease to be of international
concern. The country has also established diagnostic capacity for
COVID-19 in three laboratories within the country in one month.
Nigeria CDC has established a national team that meets daily to
assess the risk coronavirus poses to the nation and review its
response to it. Uganda quarantined more than 100 people who
arrived at Entebbe International Airport, some at hospitals in
Entebbe and Kampala, and others were confined in their homes.
Zambia has dedicated two medical facilities in the capital, Lusaka,
to quarantine people suspected of having the disease. They include
designating a new 800-bed capacity hospital in Lusaka, funded and
built by China development aid to Zambia. Thermal body scanners
have also been set up at all ports of entry to detect travelers
showing symptoms of the virus. Kenya has introduced mandatory
screening at all ports of entry, and established isolation facilities
and a rapid response team to handle suspected cases. South Africa
has set up national and provincial response teams, designated 300
health officials to ports of entry and begun screening all travelers
from China. The Africa CDC has trained numerous participants
from across Africa, including Egypt, on enhancing detection of
COVID-19 at points-of-entry in collaboration with US-CDC, WHO,
and the International Civil Aviation Authority (WHO, 2020e). Two
airlines, Kenya Airways and South African Airlines, were also
represented in the training. Additional training and resources have
been provided to Egypt and other at-risk countries for infection
prevention and control in healthcare facilities, medical manage-
ment of COVID-19, and risk communication and community
engagement. The Africa Union, West African Health Organization
(WAHO) and external donors have been quick to provide support to
the Africa CDC. In response to emergency grant calls for COVID-19,
there have been several consortia fielding grant applications for
research and capacity development.
The long anticipated and inevitable and detection of the
introduction of SARS-CoV-2 into Africa was announced on 14
February 2020, by the Minister of Health and Population of Egypt,
Dr Hala Zayed, who confirmed the first case of the novel
coronavirus disease COVID-19 in Egypt. The patient was a 33
year old male of foreign origin whose 17 contacts tested negative
but were under home quarantine for 14 days. This has ignited a
reflection on the readiness of the continent to take on the challenge
and showcase its new potential. Following detection of this first
case in Africa, the Africa CDC, Nigeria CDC and other national public
health institutes in liaison with the WHO are scaling up
preparedness efforts in the African region, supporting countries
to implement recommendations outlined by the WHO Interna-
tional Health Regulations Emergency Committee. The EmergencyCommittee recommended that all countries should be prepared for
containment, including active surveillance, early detection, isola-
tion and case management, contact tracing and prevention of
onward spread of SARS-CoV-2. Thirteen nations with close links
with China, including Nigeria, South Africa, Kenya and the
Democratic Republic of the Congo, have been identified as
especially high-risk priority zones for proactive surveillance,
detection and containing the spread of COVID-19. The WHO has
sent diagnostic kits to 29 laboratories in Africa, and reagents and
positive controls are being shipped worldwide by PANDORA-ID-
NET partner in Germany, Charité-Universitätsmedizin Berlin
Institute of Virology, to ensure the capacity to screen and test.
Some countries in Africa, including DRC, are also leveraging the
capacity they have built up to test for Ebola, to test for COVID-19.
Thus, early detection of cases with implementation of infection
control procedures will remain a priority to control the spread of
COVID-19 in Africa.
On 22nd February, 2020 an Emergency Ministerial meeting on
COVID-19 was organized by the African Union and the Africa
Centres for Disease Control and Prevention following which the
WHO DG announced several additional measures and plans for
supporting the Africa response to COVID-19 (WHO, 2020g). He
appointed Dr John Nkengasong, Director of the Africa CDC, and
Professor Samba Sow, Director-General of the Center for Vaccine
Development in Mali, as special envoys on COVID-19, to provide
strategic advice and high-level political advocacy and engagement
in Africa. A WHO Strategic Preparedness and Response Plan has
been developed, with a call for US$675 million to support those
African countries which are most vulnerable. WHO have also
shipped over 30,000 sets of personal protective equipment to
several countries in Africa, and 60,000 more sets are to be shipped
to the 19 vulnerable countries in the coming weeks. During the
past month about 11,000 African health workers have been trained
using WHO’s online courses on COVID-19, which are available free
of charge in English, French and other languages at OpenWHO.org.
As of 5th March, 2020, worldwide there were 93,090 laboratory
confirmed cases of COVID-19 reported to the WHO. Of these 80,422
cases (with 2,984 deaths) were from China, and 12,668 cases (with
214 deaths) were from 76 countries outside China. From Africa
there have been 5 cases from Algeria, 1 from Nigeria, 1 from
Senegal and 2 from Egypt (WHO, 2020f). Given the extent of the
outbreak in China, and with a high degree of awareness of COVID-
19 in Africa, and proactive screening on the rise, more COVID-19
cases are anticipated in Africa. Several lessons have been learnt
from the SARS-CoV-2 epidemic, which is the third lethal human
zoonotic coronavirus with epidemic potential to emerge past 2
decades, the first being SARS-CoV identified in 2002 and second
MERS-CoV in 2012 (Hui et al., 2014; McCloskey et al., 2014). Whilst
the news and social media hype has evoked public and political
anxieties, it is important to note that COVID-19 appears to have less
than 3% mortality rates and is not more serious than outbreaks of
viral respiratory tract infections such as influenza (Ippolito et al.,
2020). It is crucial that other communicable diseases which impact
a higher toll and burden on health services in Africa are not
neglected or sidelined by the current hype and scaremongering of
the COVID-19 epidemic.
An important need remains for ensuring long-term sustain-
ability of what is being built. Africa needs to continue its upward
trajectory of activities so as to align public health resources,
scientific expertise and experience, and political commitment so
that any future infectious disease outbreaks can be stopped before
they become an epidemic in Africa. Africa needs more investments
into ONE-HEALTH collaborative activities across the continent in
order to meet the challenges of current and future public health
threats (Kock et al., 2020; Petersen et al., 2019; Talisuna et al., 2020;
Hui et al., 2020; Zumla et al., 2016). A whole new young generation
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workers, epidemiologists, researchers, healthcare workers and
laboratory personnel have emerged over the past 5 years, and they
need to be supported by security of funding to build their careers
and sustain their capabilities to take forward their research and
training portfolios. The future of Africa’s public health security
relies on them. Increased governmental and donor investments are
required to advance locally led, world-class public health work
with surveillance, data and analytics capabilities and further
expanding state-of-the-art laboratory capacities with more trained
personnel to sustain capacity to rapidly respond to outbreaks at
their source. A well-planned long-term strategy from the Africa
Union will add major value for consolidating African leadership of
public health capacity building, training and research.
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